Skip to main content
MSDL logo
MSDL
(NYSE)
Morgan Stanley Direct Lending Fund
$15.27-- (--)
Loading... - Market loading

Morgan Stanley Direct Lending Fund (MSDL) Stock Price & Financial Analysis

Morgan Stanley Direct Lending Fund Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$15.24 - $15.45
52-Week High$19.94
52-Week Low$13.66
Open$15.40
Volume292.08K
Average Volume (3M)546.06K
Market Cap1.35B
Shares Outstanding85.78M
P/E Ratio (TTM)15.37
Forward P/E31.09
Price to Sales (P/S)5.85
Price to Book (P/B)0.80
EV/EBITDA21.68
Revenue (TTM)231.10M
Net Income (TTM)87.91M
Free Cash Flow (TTM)203.14M
EPS (TTM)$1.01
Profit Margin38.04%
Operating Margin66.00%
Return on Equity (ROE)5.20%
Debt to Equity1.21
50-Day MA$15.32
200-Day MA$15.83
52-Week Change-19.60%
Annual Dividend$1.90
Dividend Yield12.06%
Payout Ratio187.52%
Last Dividend Ex-DateJun 30, 2026

Frequently Asked Questions About Morgan Stanley Direct Lending Fund

What is the current stock price for MSDL?

As of the latest trading session, MSDL stock trades at $15.27. The 52-week range is $13.66–$19.94, with a day range of $15.23–$15.45.

What is the P/E ratio for MSDL?

Morgan Stanley Direct Lending Fund's trailing P/E ratio is 15.4, meaning investors pay $15.4 for every $1 of annual earnings. The forward P/E is 31.1, reflecting analyst expectations for future earnings. Morgan Stanley Direct Lending Fund operates in the Financials sector.

Does MSDL pay dividends?

Yes, Morgan Stanley Direct Lending Fund pays a 12.06% annual dividend yield ($1.90 per share). The payout ratio is 187.5%. The last ex-dividend date was 2026-06-30.

What do analysts recommend for MSDL?

Based on 1 analyst, the consensus for MSDL is Hold.

What is the market cap of MSDL?

Morgan Stanley Direct Lending Fund's market capitalization is $1.31B, classifying it as a small-cap company. Morgan Stanley Direct Lending Fund operates in the Financials sector within the Asset Management industry.